Cargando…
Efficacy and Safety of Botulinum Toxin vs. Placebo in Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Background: Major depressive disorder (MDD) is a serious mental disorder that represents a substantial public health problem. Several trials have been undertaken to investigate the role of botulinum toxin type A (BTX-A) in the treatment of MDD, but the conclusions were controversial. To examine the...
Autores principales: | Qian, Huan, Shao, Fangjie, Lenahan, Cameron, Shao, Anwen, Li, Yingjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746677/ https://www.ncbi.nlm.nih.gov/pubmed/33343429 http://dx.doi.org/10.3389/fpsyt.2020.603087 |
Ejemplares similares
-
A Correlative Study Between Personality Traits and the Preference of Site Selection in Cosmetic Treatment
por: Qian, Huan, et al.
Publicado: (2021) -
Response of Depression to Botulinum Toxin Treatment: Agitation as a Predictor
por: Milev, Roumen
Publicado: (2015) -
The safety and efficacy of botulinum toxin A on the treatment of depression
por: Zhang, Qilin, et al.
Publicado: (2021) -
Agitation Predicts Response of Depression to Botulinum Toxin Treatment in a Randomized Controlled Trial
por: Wollmer, M. Axel, et al.
Publicado: (2014) -
Oxidative Stress at the Crossroads of Aging, Stroke and Depression
por: Shao, Anwen, et al.
Publicado: (2020)